Macquarie Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,170
| Closed | -$17 | – | 1900 |
|
|
2024
Q1 | $17 | Buy |
+9,170
| New | +$17 | ﹤0.01% | 1696 |
|
|
2022
Q2 | – | Sell |
-3,370
| Closed | -$2 | – | 2566 |
|
|
2022
Q1 | $2 | Hold |
3,370
| – | – | ﹤0.01% | 2604 |
|
|
2021
Q4 | $8K | Hold |
3,370
| – | – | ﹤0.01% | 2530 |
|
|
2021
Q3 | $10K | Hold |
3,370
| – | – | ﹤0.01% | 2534 |
|
|
2021
Q2 | $13K | Hold |
3,370
| – | – | ﹤0.01% | 2439 |
|
|
2021
Q1 | $11K | Sell |
3,370
-1,033
| -23% | -$3.37K | ﹤0.01% | 2373 |
|
|
2020
Q4 | $12K | Hold |
4,403
| – | – | ﹤0.01% | 2284 |
|
|
2020
Q3 | $11K | Hold |
4,403
| – | – | ﹤0.01% | 2264 |
|
|
2020
Q2 | $60K | Buy |
+4,403
| New | +$60K | ﹤0.01% | 1882 |
|
|
2018
Q3 | – | Sell |
-27,000
| Closed | -$269K | – | 2146 |
|
|
2018
Q2 | $269K | Buy |
27,000
+23,100
| +592% | +$230K | ﹤0.01% | 1561 |
|
|
2018
Q1 | $37K | Sell |
3,900
-15,300
| -80% | -$145K | ﹤0.01% | 2024 |
|
|
2017
Q4 | $286K | Buy |
19,200
+9,900
| +106% | +$147K | ﹤0.01% | 1629 |
|
|
2017
Q3 | $183K | Buy |
+9,300
| New | +$183K | ﹤0.01% | 1777 |
|